PD-L1knockdown or drug interference reverses sorafenib resistance in HCC by restoring the expression of CDH1, an intercellular adhesion molecule that inhibits HCC metastasis, which is silenced by DNMT1 methylation (90). This evidence concerns the gene CDH1 and hepatocellular carcinoma.